Form 13F Confidential Treatment Requests & SEC Approvals

Quarterly Form 13F disclosures provide public markets with transparent visibility into institutional portfolios, but large asset managers frequently seek temporary exemptions. Securities legal frameworks explored in the Berkshire Hathaway 13F Warren Buffett portfolio playbook analyze how Section 13(f)(3) allows managers to request confidential treatment for multi-quarter accumulation campaigns.

To secure SEC approval for confidential treatment, an investment manager must demonstrate that premature public disclosure of an open market building program would adversely affect its ability to complete purchases at fair prices, effectively protecting against predatory front-running by copycat funds.

Warren Buffett has historically utilized confidential treatment while acquiring massive multibillion-dollar stakes in commercial banks, energy majors, and industrial leaders, delaying public filing until position sizing is complete and filings can be retrospectively amended.